Trading Signals: EXEL Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(EXELIXIS INC)
| EXEL latest price $25.7500 (-2.46%) ($25.5000 - $26.3000) on Thu. Nov. 9, 2017. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 3.5% (three month average) | | RSI | 42 | | Latest Price | $25.7500(-2.46%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | EXEL advances 0.2% a day on average for past five trading days. | | Weekly Trend | EXEL advances 0.2% a week on average for past two weeks. | | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | | Correlated ETFs | Broad market will support EXEL advance at 0% a week (0% probability)
IBB(55%) XBI(54%) IWO(46%) ARKG(43%) IWC(43%) | | Factors Impacting EXEL price | EXEL will decline at least -1.75% in a week (0% probabilities).
VIXM(-13%) TLT(-12%) UUP(-11%) SHY(-6%) IGOV(-2%) | | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.75% (StdDev 3.5%) | | Hourly BBV | 0 () | | Intraday Trend | -2% | | | | | |
|
| Resistance Level | $26.42 | | 5 Day Moving Average | $26.47(-2.72%) | | 10 Day Moving Average | $25.98(-0.89%) | | 20 Day Moving Average | $26.42(-2.54%) | | To recent high | -11.9% | | To recent low | 10.3% | | Market Cap | $7.954b | | | | | | |
Exelixis, Inc. is a biopharmaceutical company, which engages in the development, commercialization, and discovery of new medicines for the treatment of cancer. It offers products under the brands of Cometriq, Cabometyx, and Cotellic. The company was founded by Corey S. Goodman and Stelios B. Papadopoulos on November 15, 1994 and is headquartered in Alameda, CA. |